Obesity drugs are dangerous things. A new "promising" treatment from Zafgen resulted in around 13 percent lost body weight in their latest trial. Unfortunately eight patients suffered "serious" adverse effects, like pulmonary embolism, and two died.
Reuters: Zafgen Obesity Drug Succeeds in Mid-Stage Trial, Shares RiseSound like Russian roulette. Would you play?
